MMI Marcus & Millichap

NYSE
$27.75

Marcus & Millichap's Recovery Loses Speed as Rate Spike Hits Private Client and Financing Growth; the Bull Case Now Rests on 2027 and M&A

Marcus & Millichap (MMI) earned $0.03 per share on revenue of $208.37 million for the September quarter. Revenue rose 7.5% year over year, but that rate was well under half the roughly 18% growth the company posted in both the first and second quarters. Earnings Whispers' normalized figures show EPS down 66.7% year over year. On a GAAP basis, however, net income improved to $1.0 million, or $0.03 per diluted share, from $0.2 million, or $0.01, a year ago. Investors should note that conflict: the normalized comparison is negative while the GAAP comparison is positive. Either way, profitability remains thin. The central takeaway is deceleration. An 80 basis point jump in the 10-year Treasury yield during the quarter widened bid-ask spreads and stalled the parts of the business most sensitive to rates. That broke the momentum of what management had called a broad-based recovery only a quarter earlier.

The quality of the quarter deserves scrutiny. MMI still posted an operating loss of $0.9 million. Pre-tax income of $2.6 million depended on $3.7 million of other income, mostly interest on its cash and securities. Year-over-year SG&A comparisons were also flattered because the prior-year quarter included a $4.0 million legal accrual. Underneath, margins weakened. Cost of services rose 160 basis points to 64.0% of revenue because senior producers earned higher commissions, which was a sharper increase than the 50 basis point rise in Q2. Adjusted EBITDA grew 20% year over year to $8.2 million, but it fell sequentially from about $12 million in Q2. That figure also excludes $6.8 million of stock-based compensation.

The brokerage metrics show where growth went. Brokerage dollar volume rose 12.6% to $9.4 billion, yet transaction count was flat at 1,584. That compares with growth of 11% in Q2 and 15% in Q1. The average commission rate fell nine basis points to 1.85% as the mix shifted toward larger deals. Private Client Market revenue, the firm's core franchise, grew just 3.6%, down from 14% in Q2, and deal count in that segment slipped slightly. Middle Market and Larger Transaction revenue rose 18.1% to $62.0 million. Middle market growth accelerated to 17% from 13% in Q2, although growth in larger transactions cooled to 20% from 43%. Financing was the starkest slowdown. Fees grew only 2.6% on 0.7% volume growth, compared with 15% growth in Q2 and 48% in Q1. Headcount is another warning sign. MMI ended September with 1,670 sales and financing professionals, flat year over year but well below the 1,808 reported at the end of 2025. Management acknowledged elevated new-agent turnover.

Management's tone shifted noticeably. Instead of celebrating the strongest first half since 2022, it described rate volatility as frustrating and characterized the Q4 outlook as measured. Q4 also faces a tough comparison, since the prior-year quarter benefited from the permanent bonus depreciation provision. The release says near-term challenges are expected to extend through 2026. The forward case is now longer-dated:

  • **Listings:** management cited near-record listing inventory entering 2027 at more realistic prices.
  • **Loan maturities:** roughly $1.2 trillion of loans mature in 2027 and 2028, and lenders are pushing for resolution rather than extensions.
  • **Rates:** the 10-year yield has eased to about 4.85% from roughly 5.3%.
  • **Acquisitions:** outside advisors have been hired to pursue deals, with financing firms and boutique mortgage banks as targets.
  • **New initiatives:** the company added a retail leasing build-out and new enterprise and AI systems.

These initiatives carry a cost. Management expects incremental strategic spending of 1% to 2% of revenue over the next 18 to 24 months, and leasing is not expected to contribute meaningfully in 2027.

Capital allocation also changed. MMI repurchased no shares in Q3, after buying back about $24 million in Q2 and $23 million in Q1, in order to preserve capital for M&A. The balance sheet supports that choice. Cash and marketable securities rose to about $373 million with no debt, and the semi-annual $0.25 dividend continues. Still, pausing buybacks while the stock trades near levels where the company bought aggressively this year (an average of $26.22) signals a bet on deals rather than on its own shares.

On the market side, shares opened at $32.70 after the August report, comfortably above the 200-day moving average, which now sits at $28.78. That level is a useful reference point. The August rally was built on an acceleration story that this quarter undercuts, so the stock's relationship to the longer-term average may show whether investors treat Q3 as a rate-driven pause or a broken recovery. Current sentiment and pricing data were not available.

The bottom line is that MMI delivered growth and positive GAAP earnings, but the quarter marks a clear inflection lower. Private client and financing momentum faded, margins tightened, agent count is down from year-end, and management pushed the payoff into 2027 while adding expenses and pausing buybacks. Bulls can point to a fortress balance sheet, a building wave of forced transactions, and easing yields. Bears have legitimate ammunition in a recovery that proved highly sensitive to rates and lacks a defined timeline.

← Back to MMI news